Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

German IPO candidates hope for post-summer debuts

Published 26/07/2023, 16:21
Updated 26/07/2023, 16:27
© Reuters. FILE PHOTO: The German share price index DAX graph is pictured at the stock exchange in Frankfurt, Germany, July 24, 2023.    REUTERS/Staff/File Photo

By Pablo Mayo Cerqueiro and Emma-Victoria Farr

LONDON/FRANKFURT (Reuters) - Hopes have mounted for a revival in stock listings in Germany despite signs of faltering economic growth, as at least four initial public offerings (IPOs) have been pencilled in for later this year, four people familiar with matter said.

The IPO market has been slow to recover after Russia's invasion of Ukraine and the fastest tightening of monetary policy in decades all but froze listings last year.

Europe's largest economy has only seen two IPOs this year, raising a combined 1 billion euros ($1.11 billion). But the people, who spoke on condition of anonymity, told Reuters the pace could pick up.

Schott Pharma, the medical glass division of Schott AG, is preparing to launch an IPO in Frankfurt after the lull over the summer months, while defence contractor Renk might go public before the end of the year if its private equity owner Triton rules out a private sale, they said.

Road payments group DKV Mobility, backed by CVC Capital Partners, and mid-size lender OLB Bank, backed by Apollo Global Management, are also considering a 2023 debut if market conditions allow, the people added.

No final decisions have been made, and timelines could slip into next year, the people cautioned. However, the groundwork has been carried out to allow the companies to act quickly if the opportunity arises, they said.

Spokespeople for Apollo, CVC, DKV Mobility, Renk, Schott and Triton declined to comment. An OLB representative said the bank continues to plan for an IPO but the decision ultimately lies with its shareholders.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

DEFERRED AMBITION

Excluding Porsche (ETR:P911_p)'s blockbuster offering late last year, German IPOs raised just over 300 million euros in 2022, according to Dealogic data, as a surge in interest rates and Russia's invasion of Ukraine forced companies to defer their listing ambitions.

OLB scrapped plans to go public earlier this year after the sudden fall of Silicon Valley Bank in March stoked fears of a global bank run.

Equity markets have since rallied as investors see a possible end to interest rate hikes meant to tame inflation.

European stocks are up 9% from January, with Germany's DAX index up 15% year to date, while volatility is at a level that bankers say is conducive to deals.

The IPO market has also shown signs of improvement.

Earlier this month, Hydrogen firm Thyssenkrupp (ETR:TKAG) Nucera sought to take advantage of improving market sentiment by listing on the Frankfurt Stock Exchange.

Shares in Nucera closed on Tuesday at 21.88 euros, above the price of its IPO.

However, web hosting services provider IONOS has stayed stuck below the price of its February IPO and Germany's economy remains slow. A closely watched survey of German business showed deteriorating morale this week.

($1 = 0.9043 euros)

Latest comments

In these articles they see all positive. Too bad the reality is quite different.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.